The National Center for Fatality Review and Prevention

Resource Tag: Data Analysis

  • COVID-19 and Pregnancy: A Look at Adverse Maternal and Neonatal Outcomes

    SARS-CoV-2, the cause of coronavirus disease 2019 (COVID-19), has been associated with significant maternal morbidity and poor neonatal outcomes, including preterm birth and stillbirth. Fatality review teams are collecting and analyzing information on cases of fetal, infant, and child deaths that are directly attributed to COVID-19, and those that are indirectly impacted by the pandemic. Learn from expert speakers the latest information on prevalence, risk factors, and the most current guidelines for medical/obstetric care and preventive strategies for pregnant patients with COVID-19.

    Webinar (passcode: NCFRP)
    Slides (PDF)

    Other Resources:
    COVID and Pregnancy Report (PDF)
    CDC Infographic on COVID-19 and Pregnancy (PDF)
    Resources: COVID-19 Vaccination in Pregnancy (PDF)

  • What Teams Need to Know about Infant Mental Health

    Infant Mental Health (IMH) is the study of mental health as it applies to infants, toddlers, and their families. The field investigates optimal social and emotional development of infants and their families in the first three years of life. Understanding infant mental health is the key to preventing and treating the mental health problems of very young children and their families. This webinar aims to assist fatality review personnel in exploring when a referral to an IMH provider is needed and what services an IMH provider can offer a family.

    Webinar (passcode: NCFRP)
    Slides (PDF)
    U.S. Alliance Map (PDF)
    Reflective Supervision (PDF)
    MI-AIMH Developmental Wheels (PDF)
    IMH Toolkit (PDF)

  • Improving Our Understanding of Infants with Substance Exposure and Neonatal Abstinence Syndrome (NAS)

    What is the difference is between an infant born substance exposed and an infant born with neonatal abstinence syndrome (NAS)? Dr. Nancy K. Young answers this and other questions covering opioid use disorders; substance use during pregnancy; the difference between NAS and substance exposure; best practices for collaboration and plans of safe care; and suggestions for what fatality review teams can do to address the needs of families affected by substance use disorders.

    Webinar (passcode: NAS)
    Slides (PDF)
    Questions and Answers (PDF)

  • Review of Infant Deaths due to Congenital Anomalies

    This presentation will discuss the most common congenital anomalies, steps for evaluation and prevention of possible anomalies, and tips for effective review including family history, chart review, and risk of recurrence.

    Webinar (passcode: NCFRP)
    Slides (PDF)
    Q&A (PDF)

  • Sleep Related SUID Guidelines

    Guidance for determining child maltreatment in section I5 for sleep-related Sudden Unexpected Infant Deaths (SUIDs) (PDF)

  • Improving Consistency of Child Maltreatment Identification for Sleep-Related SUID

    This webinar discusses guidelines that were developed to help CDR teams more consistently classify child maltreatment for sleep-related SUIDs.

    Webinar (passcode: NCFRP)
    Slides (PDF)

  • Fatality Review Data

    View the fatality review data and trends at https://fatalityreview.org